Do analysts prefer NUS or COTY?

Coty has a consensus target price of $3.70, suggesting a potential upside of 86.11%. Given Coty's higher probable upside, analysts clearly believe Coty is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Coty 3 Sell rating(s) 13 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.88

Do analysts rate NUS or NATR?

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 69.41%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nature's Sunshine Products 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts recommend NUS or USNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer MED or NUS?

Medifast currently has a consensus price target of $12.00, indicating a potential downside of 1.72%. Given Medifast's higher probable upside, equities analysts plainly believe Medifast is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate NUS or VERU?

Veru has a consensus target price of $23.00, indicating a potential upside of 887.12%. Given Veru's stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Veru 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable valuation and earnings, NUS or VERU?

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nu Skin Enterprises $1.44B 0.19 $160.20M $1.10 5.05 Veru $16.89M 2.21 -$22.73M -$0.89 N/A

Is NUS or VERU more profitable?

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity. Company Net Margins Return on Equity Return on Assets Nu Skin Enterprises 3.78% 7.47% 4.21% Veru N/A -54.72% -39.09%

Nu Skin Enterprises (NUS) Competitors

$5.52 -0.08 (-1.43%)

As of 10:47 AM Eastern

Compare

NUS vs. COTY, NATR, USNA, MED, and VERU

Should you buy Nu Skin Enterprises stock or one of its competitors? MarketBeat compares Nu Skin Enterprises with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nu Skin Enterprises include Coty (COTY), Nature's Sunshine Products (NATR), USANA Health Sciences (USNA), Medifast (MED), and Veru (VERU).

How does Nu Skin Enterprises compare to Coty?

Nu Skin Enterprises (NYSE:NUS) and Coty (NYSE:COTY) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 42.4% of Coty shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 5.9% of Coty shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Coty had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 1 mentions for Coty and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.50 beat Coty's score of 0.49 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company	Overall Sentiment
Nu Skin Enterprises	Positive
Coty	Neutral

Nu Skin Enterprises has higher earnings, but lower revenue than Coty. Coty is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.44B	0.19	$160.20M	$1.10	5.05
Coty	$5.89B	0.30	-$367.90M	-$0.62	N/A

Nu Skin Enterprises has a net margin of 3.78% compared to Coty's net margin of -9.20%. Nu Skin Enterprises' return on equity of 7.47% beat Coty's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Coty	-9.20%	4.59%	1.47%

Coty has a consensus target price of $3.70, suggesting a potential upside of 86.11%. Given Coty's higher probable upside, analysts clearly believe Coty is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Coty	3 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Nu Skin Enterprises has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market. Comparatively, Coty has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

Summary

Nu Skin Enterprises beats Coty on 9 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Nature's Sunshine Products	4.06%	14.67%	9.27%

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 69.41%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Nature's Sunshine Products and 0 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 1.51 beat Nu Skin Enterprises' score of 0.50 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Overall Sentiment
Nu Skin Enterprises	Positive
Nature's Sunshine Products	Very Positive

Nu Skin Enterprises has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.44B	0.19	$160.20M	$1.10	5.05
Nature's Sunshine Products	$480.14M	0.76	$19.52M	$1.10	18.78

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 11 of the 15 factors compared between the two stocks.

How does Nu Skin Enterprises compare to USANA Health Sciences?

Nu Skin Enterprises (NYSE:NUS) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
USANA Health Sciences	0.96%	6.21%	4.50%

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.44B	0.19	$160.20M	$1.10	5.05
USANA Health Sciences	$925.26M	0.35	$10.76M	$0.47	37.74

In the previous week, USANA Health Sciences had 6 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 6 mentions for USANA Health Sciences and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.50 beat USANA Health Sciences' score of 0.29 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company	Overall Sentiment
Nu Skin Enterprises	Positive
USANA Health Sciences	Neutral

Nu Skin Enterprises has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Summary

Nu Skin Enterprises beats USANA Health Sciences on 10 of the 14 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Medifast?

Medifast (NYSE:MED) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Medifast currently has a consensus price target of $12.00, indicating a potential downside of 1.72%. Given Medifast's higher probable upside, equities analysts plainly believe Medifast is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nu Skin Enterprises has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$346.10M	0.39	-$18.67M	-$1.83	N/A
Nu Skin Enterprises	$1.44B	0.19	$160.20M	$1.10	5.05

Nu Skin Enterprises has a net margin of 3.78% compared to Medifast's net margin of -5.78%. Nu Skin Enterprises' return on equity of 7.47% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	-5.78%	-4.80%	-3.83%
Nu Skin Enterprises	3.78%	7.47%	4.21%

95.5% of Medifast shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 54.1%. Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 4.3%. Medifast pays out -360.7% of its earnings in the form of a dividend. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Medifast is clearly the better dividend stock, given its higher yield and lower payout ratio.

Medifast has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market.

In the previous week, Medifast had 13 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 13 mentions for Medifast and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.50 beat Medifast's score of 0.37 indicating that Nu Skin Enterprises is being referred to more favorably in the news media.

Company	Overall Sentiment
Medifast	Neutral
Nu Skin Enterprises	Positive

Summary

Nu Skin Enterprises beats Medifast on 10 of the 17 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Veru?

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap personal products companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.44B	0.19	$160.20M	$1.10	5.05
Veru	$16.89M	2.21	-$22.73M	-$0.89	N/A

In the previous week, Veru had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Veru and 0 mentions for Nu Skin Enterprises. Veru's average media sentiment score of 1.42 beat Nu Skin Enterprises' score of 0.50 indicating that Veru is being referred to more favorably in the news media.

Company	Overall Sentiment
Nu Skin Enterprises	Positive
Veru	Positive

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Veru	N/A	-54.72%	-39.09%

Veru has a consensus target price of $23.00, indicating a potential upside of 887.12%. Given Veru's stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Nu Skin Enterprises has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market. Comparatively, Veru has a beta of -1.14, meaning that its share price is 214% less volatile than the broader market.

Summary

Nu Skin Enterprises beats Veru on 9 of the 16 factors compared between the two stocks.

Get Nu Skin Enterprises News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NUS vs. The Competition

Export

Metric	Nu Skin Enterprises	COSMETICS&TLTRS Industry	Staples Sector	NYSE Exchange
Market Cap	$269.94M	$2.97B	$15.77B	$23.14B
Dividend Yield	4.15%	4.92%	3.52%	4.09%
P/E Ratio	5.05	30.14	25.60	31.05
Price / Sales	0.19	19.62	46.88	14.77
Price / Cash	2.33	15.24	16.95	24.80
Price / Book	0.33	2.24	5.57	4.69
Net Income	$160.20M	-$203.95M	$676.04M	$1.07B
7 Day Performance	-7.87%	2.36%	-0.89%	-0.08%
1 Month Performance	-22.83%	3.45%	-2.65%	0.80%
1 Year Performance	-30.63%	-25.22%	-12.19%	26.11%

Nu Skin Enterprises Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NUS Nu Skin Enterprises	3.1268 of 5 stars	$5.52 -1.4%	N/A	-32.5%	$268.00M	$1.44B	5.02	2,800
COTY Coty	4.6578 of 5 stars	$2.04 +0.2%	$3.70 +82.0%	-58.7%	$1.79B	$5.89B	N/A	11,636
NATR Nature's Sunshine Products	3.9279 of 5 stars	$21.85 flat	$35.00 +60.2%	+48.4%	$384.23M	$480.14M	19.86	850	Positive News
USNA USANA Health Sciences	2.6495 of 5 stars	$18.79 +0.2%	N/A	-38.0%	$346M	$925.26M	39.97	1,570	Positive News
MED Medifast	1.4904 of 5 stars	$12.60 +0.1%	$12.00 -4.8%	-6.9%	$139.99M	$385.79M	N/A	870

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NUS) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nu Skin Enterprises (NUS) Competitors

NUS vs. COTY, NATR, USNA, MED, and VERU

How does Nu Skin Enterprises compare to Coty?

Summary

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Summary

How does Nu Skin Enterprises compare to USANA Health Sciences?

Summary

How does Nu Skin Enterprises compare to Medifast?

Summary

How does Nu Skin Enterprises compare to Veru?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUS vs. The Competition

Nu Skin Enterprises Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nu Skin Enterprises (NUS) Competitors

NUS vs. COTY, NATR, USNA, MED, and VERU

How does Nu Skin Enterprises compare to Coty?

Do insiders and institutionals hold more shares of NUS or COTY?

Does the media prefer NUS or COTY?

Which has stronger earnings and valuation, NUS or COTY?

Is NUS or COTY more profitable?

Do analysts prefer NUS or COTY?

Which has more risk and volatility, NUS or COTY?

Summary

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Do insiders & institutionals believe in NUS or NATR?

Is NUS or NATR more profitable?

Do analysts rate NUS or NATR?

Does the media prefer NUS or NATR?

Which has more risk and volatility, NUS or NATR?

Which has better valuation and earnings, NUS or NATR?

Summary

How does Nu Skin Enterprises compare to USANA Health Sciences?

Do analysts recommend NUS or USNA?

Is NUS or USNA more profitable?

Do insiders and institutionals believe in NUS or USNA?

Which has higher earnings and valuation, NUS or USNA?

Does the media prefer NUS or USNA?

Which has more volatility and risk, NUS or USNA?

Summary

How does Nu Skin Enterprises compare to Medifast?

Do analysts prefer MED or NUS?

Which has stronger valuation and earnings, MED or NUS?

Is MED or NUS more profitable?

Do insiders and institutionals hold more shares of MED or NUS?

Is MED or NUS a better dividend stock?

Which has more volatility and risk, MED or NUS?

Does the media favor MED or NUS?

Summary

How does Nu Skin Enterprises compare to Veru?

Which has preferable valuation and earnings, NUS or VERU?

Does the media refer more to NUS or VERU?

Do insiders & institutionals have more ownership in NUS or VERU?

Is NUS or VERU more profitable?

Do analysts rate NUS or VERU?

Which has more volatility and risk, NUS or VERU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUS vs. The Competition

Nu Skin Enterprises Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools